Screening Flashcards

1
Q

what is the process of screening

A

a process of identifying apparently healthy people who may be at an increased risk of a disease or condition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is the purpose of screening

A

this is ultimately to save lives or improve the quality of life through early risk identification and tp reduce the risk of developing a serious condition or the bad complications that go along with it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what are some examples of screening in adults

A
AAA - one off scan
Bowel cancer - every 2 years 
Breast cancer - every three years 
Cervical cancer - every three beats 
diabetic retinopathy - annually
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

requirements of the condition to be screened

A

important public health problem
natural history is understood
recognisable latent or early symptomatic phase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

requirements of the test to be screened

A

simple, safe, precise and validated
acceptable
distribution of test results down and cut off defines
agreed policy on further diagnostic investigations

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

requirements of the treatment

A

effective and available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are requirements of the screening programme itself

A

evidence from RTC that screening is effective/accurate
clinically, socially, ethically acceptable
cost effective
quality assured

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is sensitivity and how is it calculated

A

this is how well the test picks up having the disease

= the number of results where disease detected in people with the disease
/
number of people with the disease
x100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is specificity and how is it calculated

A

this is how well the test detects not having the disease

= number of ‘normal’ results where the disease is not detected in people without the disease
/
the number of people without the disease
x100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what does high sensitivity and specificity show

A
  • picks up most of the disease
  • very few false negatives
  • correctly detects no disease
  • very few false positives
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

positive predictavice value, what is it and how’s it calculated

A

how reliable the test result which shows the disease is present

= number of people with the disease and a positive test result
/
number of people with a positive test result
x100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

negative predictavice value, what is it and how’s it calculated

A

how reliable is the test result showing disease is NOT present

= number of people who do not have the disease and have a negative test result
/
the number of people with a negative test result
x100

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what are the benefits of screening

A
reduced disease incidence 
reduced disease mortality 
earlier, less radical treatment 
cost-effective 
overall population benefit
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the harms of screening

A
false reassurance 
over-investigation and treatment 
anxiety 
longer period od morbidity with unaltered prognosis 
harm from the screening itself 
opportunity costs 
increased health inequalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what was the outcome of the marmot review

A

Weighed the benefits and the harms of the breast cancer screening
there should e. ore communication of the associated harms and benefits to women
but is still very benefical

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what biases are there that exist in screening

A
  • participant (volunteer) bias
  • lead-time bias = length of time between the detection of a disease and its clinical presentation
  • length-time bias = detection of less aggressive forms of condition in screening
17
Q

how do you measure the effectiveness of screening

A

randomised controlled trial
– Time trend studies
– Case control studies
– Modelling studies

18
Q

results from inequality of treatment

A

Ethical issue about equitable access and outcomes
• Legal requirements of Equality Act (see notes)
• Increased cost of treatment, social care etc
• Less inequality may be better for everyone*

19
Q

results from inequality in screening

A

• Reduced effectiveness of the screening programme
• Potentially non-viability of the programme
So let’s look at some of the issues around improving the